Recognition and diagnosis of breakthrough pain

Pain Medicine

Volumn 8, Issue SUPPL. 1, 2007, Pages

  Payne, Richard ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Analgesics; Cancer; Diagnosis; Opioid; Pain; Palliative Care

Indexed keywords

ANALGESIC AGENT; OPIATE;

ANALGESIA; BREAKTHROUGH PAIN; CANCER PATIENT; CHRONIC PATIENT; CONSENSUS; DISEASE CLASSIFICATION; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; NEUROPATHIC PAIN; PAIN; PAIN ASSESSMENT; PATIENT ASSESSMENT; PHYSICIAN; QUALITY OF LIFE; REVIEW; VISCERAL PAIN;

CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEOPLASMS; PAIN; PAIN MEASUREMENT; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 33846385707     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2006.00269.x     Document Type: Review

References (23)

1. Gureje OKM, Simon GE, Gater R. Persistent pain and well-being: A World Health Organization study in primary care. JAMA 1998; 280: 147-51.
2. Swanwick M, Haworth M, Lennard RF. The prevalence of episodic pain in cancer: A survey of hospice patients on admission. Palliat Med 2001; 15: 9-18.
3. Fortner BV, Okon TA, Portenoy RK. A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain. J Pain 2002; 3: 38-44.
4. Portenoy RK, Hagen NA. Breakthrough pain: Definition, prevalence and characteristics. Pain 1990; 41: 273-81.
5. Zeppetella G, O'Doherty CA, Collins S. Prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospice. Palliat Med 2001; 15: 243-6.
6. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 1999; 82: 263-74.
7. Hanks G, Portenoy RK, MacDonald N, Forbes K. Difficult pain problems. In: Doyle D, Hanks GWC, MacDonald N, eds. Oxford Textbook of Palliative Medicine, 2nd edition. New York: Oxford University Press; 1998: 454-77.
8. Coluzzi PH. Cancer pain management: Newer perspectives on opioids and episodic pain. Am J Hosp Palliat Care 1998; 15:13-22.
9. Bennett D, Burton A, Fishman S, et al. Consensus panel recommendations for the assessment and management of breakthrough pain. Part 1 Assessment. Pharmacy & Therapeutics 2005; 30: 296-301.
10. Abrahm JL. Assessing the patient in pain. In: Abrahm JL, ed. A Physician's Guide to Pain and Symptom Management in Cancer Patients, 2nd edition. Baltimore, MD: Johns Hopkins University Press; 2005: 107-47.
11. National Cancer Institute. Pain (PDQ®) health professional version 2005. Available at: http://www.nci.nih.gov/cancertopics/pdq/ supportivecare/pain/HealthProfessional (accessed December 12, 2005).
12. Hwang SS, Chang VT, Kasimis B. Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain 2003; 101: 55-64.
13. Grant M, Ferrell BR, Rivera LM, Lee J. Unscheduled readmissions for uncontrolled symptoms. A health care challenge for nurses. Nurs Clin North Am 1995; 30: 673-82.
14. Fortner BV, Demarco G, Irving G, et al. Description and predictors of direct and indirect costs of pain reported by cancer patients. J Pain Symptom Manage 2003; 25: 9-18.
15. Goudas LC, Bloch R, Gialeli-Goudas M, Lau J, Carr DB. The epidemiology of cancer pain. Cancer Invest 2005; 23: 182-90.
16. Svendsen KB, Andersen S, Arnason S, et al. Breakthrough pain in malignant and non-malignant diseases: A review of prevalence, characteristics and mechanisms. Eur J Pain 2005; 9: 195-206.
17. Manek NJ, MacGregor AJ. Epidemiology of back disorders: Prevalence, risk factors, and prognosis. Curr Opin Rheumatol 2005; 17: 134-40.
18. Portenoy RK, Bennett DS, Rauck R, et al. Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. J Pain 2006; 7: 583-91.
19. Gomez-Batiste X, Madrid F, Moreno F, et al. Breakthrough cancer pain: Prevalence and characteristics in patients in Catalonia, Spain. J Pain Symptom Manage 2002; 24: 45-52.
20. National Comprehensive Cancer Network and American Cancer Society. Cancer Pain Treatment Guidelines for Patients - Version II. Atlanta: American Cancer Society; 2005.
21. Bennett D, Burton A, Fishman S, et al. Consensus panel recommendations for the assessment and management of breakthrough pain. Part 2 Management. Pharmacy & Therapeutics 2005; 30: 354-61.
22. Abrahm JL. Nonpharmacologic strategies for pain and symptom management. In: Abrahm JL, ed. A Physician's Guide to Pain and Symptom Management in Cancer Patients, 2nd edition. Baltimore, MD: Johns Hopkins University Press; 2005: 279-316.
23. National Pain Education Council. Pain Assessment and Documentation Tool and Guidebook. Stamford, CT: National Pain Education Council; 2003.